IDEAYA Biosciences (IDYA) Current Leases (2019 - 2026)
IDEAYA Biosciences (IDYA) posted Current Leases of $350000.0 for Q1 2026, up 3.24% sequentially from $339000.0 in Q4 2025, and up 13.64% YoY from $308000.0 in Q1 2025.
IDEAYA Biosciences (IDYA) Current Leases (2019 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Current Leases for 8 years, with the latest figure at $350000.0 in Q1 2026.
- Quarterly Current Leases rose 13.64% year-over-year to $350000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350000.0 (up 13.64% YoY) and the FY2025 annual result came in at $339000.0, up 13.76% from the prior year.
- Current Leases advanced to $350000.0 in Q1 2026 per IDYA's latest filing, from $339000.0 in the prior quarter.
- Over five years, Current Leases peaked at $2.1 million in Q3 2023 and troughed at $298000.0 in Q4 2024.
- A 5-year average of $1.2 million and a median of $1.4 million in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases gained 14.78% in 2023, then slumped 82.94% in 2024.
- Over 5 years, Current Leases stood at $1.9 million in 2022, then dropped by 6.63% to $1.7 million in 2023, then plunged by 82.94% to $298000.0 in 2024, then climbed by 13.76% to $339000.0 in 2025, then advanced by 3.24% to $350000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $350000.0, $339000.0, and $328000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Mn |
| Mar 31, 2026 | 350,000.00 |
| Dec 31, 2025 | 339,000.00 |
| Sep 30, 2025 | 328,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 308,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Jun 30, 2024 | 606,000.00 |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 1.66 Mn |
| Jun 30, 2021 | 1.62 Mn |